Objectives: Demonstrate the usability of a new polyetheretherketone (PEEK)-based MR-compatible guidewire for renal artery catheterization, angioplasty, and stenting under MR-guidance using MR-visible markers, in vitro and in vivo.
D
uring the last decades endovascular interventions were performed under guidance by fluoroscopic angiography. As drawbacks fluoroscopy exposes patient and interventional radiologist to accumulating doses of ionizing radiation and is limited to 2-dimensional images. Magnetic resonance angiography (MRA) avoids radiation exposure, provides superior soft-tissue contrast, offers 3D reconstruction capabilities and allows the depiction of functional parameters like flow, tissue oxygenation, diffusion, and perfusion. Furthermore, the application of solutions and drugs to the vessel wall during angioplasty may be monitored by magnetic resonance guidance in the future. 1 In vivo research studies have shown that MR-guided endovascular interventions are feasible in different vascular territories. [2] [3] [4] [5] [6] [7] For theses purposes nonbraided catheters, balloons, and stents commercially available today, may already be used in the magnetic field. As a crucial drawback, there are no guidewires commercially available for safe procedure guidance in an MRI environment. Lacking such an MR-compatible and MR-safe guidewire, even more recent studies used complex actively tracked devices in combination with either standard nitinol guidewires or a 0.030Љ loopless nitinol guidewire antenna. 8, 9 The key features of a clinically applicable guidewire are safety, simplicity, visibility, steerability, pushability, robustness, device support, and torque control.
Guidewires with a stainless steel core may be drawn into the magnet and those with a nonmagnetic nitinol core, still bear the risk of radiofrequency (RF)-induced heating and spark yielding in vivo because of their conductivity. 10 -12 As a first prototype, Mekle et al first described a 0.035Љ MR-compatible guidewire with a core of polyetheretherketone (PEEK), being passively marked with small iron particles embedded in a polymer coating along the axis of the wire. 13 The major drawback of this PEEK wire prototype was the floppiness, which did not allow adequate support for catheter guidance.
To gain device visibility in magnetic resonance imaging, different device tracking techniques have been investigated. 14, 15 The so called active tracking approaches in general are technically more sophisticated and were investigated by using micro coils wired dipole antennas, or self-resonant RF circuits for device detection. 16 -20 Passive tracking techniques in general are technically more simple and robust and rely on the linkage of either positive (eg, gadolinium) or negative markers (eg, paramagnetic rings or ferrite mixtures) to the vascular device (eg, catheter, guidewire). 13, 21, 22 Today endovascular treatment of renal artery stenoses (RAS) percutaneous transluminal renal angioplasty (PTRA) with or without stenting of RAS is broadly established. 23, 24 Earlier studies showing feasibility of such interventions under MR-guidance were limited and not transferable into human because of safety issues regarding the used guidewire. These studies were performed in swine by using gadolinium-filled catheters or a multipurpose catheter with attached dysprosium markers and a standard nitinol guidewire. 5, 8, 25 In our study, we used the renal arteries as a target for endovascular treatment to test different key features of the newly developed wire. As renal arteries branch from the abdominal aorta in an acute angle, either good pushability, torqubility, and wire support for catheters, balloons and stents is mandatory to allow selective vessel engagement, device guidance, and positioning without kinking, guidewire luxation, or device dislocation.
The purpose of this study was to demonstrate usability of the new MR-safe and visible PEEK-based and glass fiber-reinforced guidewire for renal artery catheterization, angioplasty, and stenting under pure MR-guidance in vitro and in vivo.
MATERIALS AND METHODS

PEEK-Based Guidewire
A 0.035Љ MR-safe guidewire (160 cm long) developed ( The bending stiffness of the PEEK-based wire was examined in comparison with commercially available hydrophilic 0.035Љ guidewires (Stiff Shaft Glidewire and Standard Glidewire; Terumo, Leuwen, Belgium). Therefore, guidewires were mechanically fixated and along their axis, forces were documented, that were needed to bend the wires by 3 mm using a mechanical caliper ( Fig. 2A) .
Nonwirebraid Catheters
Standard braided catheters are reinforced with nitinol or stainless steel along their axes. To reduce the associated in vivo risks discussed above, we exclusively used nonwirebraided catheters for phantom and animal experiments. For the phantom experiments we used a 5-French SOS catheter (SOS OMNI Selective, Angiodynamics, Queensbury, NY). In the animal studies we used a 4-French vertebral catheter (SOFTouch, Merit Medical, Galway, Ireland) and a 4-French Cobra 2 catheter (SOFTouch, Merit Medical, Galway, Ireland). All catheters were passively marked at the catheter head, as described below.
Passive Device-Marking Technique
The passive marking in our application ("MagnaFy") is applied by paramagnetic iron oxide nanoparticles composed of alfaFe 3 O 4 (90% wt/wt), with a mean size of 200 nm and a spherical shape (MagnaMedics GmbH, Aachen, Germany). The iron oxide nanoparticles are dispersed into an adhesive coating and tetrahydrofurane and then focally applied onto the PEEK-based guidewire and the otherwise commercially available nonbraided catheters (Fig. 1 ). The applied markers were 0.03-mm thick and 1.5-mm broad. The PEEK guidewire used in the phantom and animal experiments had 4 distal markers being spaced by 20 mm. In addition, for the animal experiments we added 2 markers further proximally, being separated by 40 mm, to gain better detection of the guidewire shaft.
Phantom Studies
Experiments were conducted at the Department of Radiology, University Hospital Basel, Switzerland using a 1.5-T whole-body scanner (Espree, Siemens Healthcare, Erlangen, Germany) equipped with a high-performance gradient system (gradient strength: 33 mT/m; slew rate: 100 T/m/s). The anatomic aortic silicon phantom had an infrarenal aortic aneurysm (T-R-N-002 and A-S-A-004, Elastrat, Geneva, Switzerland). We artificially created relevant (Ͼ50%) bilateral postostial high grade RAS by ligation. The PEEK-based guidewire was first advanced into the suprarenal portion of the abdominal aorta (a). Then the SOS (5 F) catheter was advanced into the suprarenal aortic segment over the wire (b), the guidewire was retracted and the catheter, configured (c). SOS catheter was pulled back, engaging the renal artery (d). The guidewire was then again (e) advanced into the renal artery and the SOS catheter was removed. A 4/40 mm PTA balloon (Pheron, Biotronik, Buelach, Switzerland) was (f) positioned in the renal artery and inflated with 1 to 2 mL (0.025 mmol/L) Gd-DOTA (Dotarem, Guerbet, Roissy CDG Cedex, France).
Procedure times were recorded. Success rates (2 grades: Ϯ) of any procedure step were documented and guidewire visibility, pushability, steerability, and device support (3 grades: poor ͓ϩ͔; acceptable ͓ϩϩ͔; good ͓ϩϩϩ͔) were assessed by the interventional radiologist.
Animal Studies
The animals were used according to the policies for the human care and use of animals, all procedures were approved by the regional and institutional animal care and use committee (G 949/07). In vivo experiments were performed in 2 domestic pigs (70 kg BW).
Animal preparation was conducted by an interventional radiologist, a surgeon, and a veterinarian (H.K., G.M.K., S.A.) according to an earlier published protocol. 26 Experiments were conducted using a 1.5-T whole-body scanner (Espree, Siemens Healthcare, Erlangen, Germany) equipped with a high-performance gradient system (gradient strength: 33 mT/m; slew rate: 100 T/m/s) and standard surface receive coils. In the animal studies, a fast gradient echo T1-FLASH sequence (BEAT-IRT) with the following imaging parameters was applied: field of view of 400 ϫ 358 mm; voxel size of 2.3 ϫ 1.4 ϫ 5.0 mm; matrix size of 288 ϫ 172; repetition time of 8.12 milliseconds; echo time of 5.24 milliseconds; flip angle of 21°; bandwidth of 299 Hz/pixel. The images were displayed on an 18" in-room monitor (Siemens Healthcare, Erlangen, Germany) beside the MR-scanner with a frame rate of 2/3 per second. To allow better vascular depiction a single intravenous injection of the bloodpool contrast media gadofosveset (Vasovist, BayerSchering Pharma, Berlin, Germany) was given immediately prior to the intervention in a dosage of 0.03 mmol Gd/kg body weight for gadofosveset.
The PEEK-based guidewire was first advanced into the suprarenal portion of the abdominal aorta (a). The 4-French vertebral catheter (SOFTouch, Merit Medical, Galway, Ireland) or 4-French Cobra 2 catheter (SOFTouch, Merit Medical, Galway, Ireland) was advanced into the suprarenal aorta over the wire (b). Guidewire was retracted and the (c) catheter was pulled back, engaging the renal artery (d).
To document the catheter position and search for potential complications (eg, perforation, dissection, and renal infarction) a 3D CE-MRA was performed. The guidewire was again (e) advanced into the renal artery and the catheter was removed. A 5/40-mm PTA balloon (Pheron, Biotronik, Buelach, Switzerland) was positioned in the renal artery and inflated with 1 to 2 mL (0.025 mmol/L) Gd-DOTA (Dotarem, Guerbet, Roissy CDG Cedex, France) (f). In both animals, catheterization and PTA of the renal artery was performed on both sides twice (n ϭ 8).
Thereafter, with the guidewire in the renal artery, the 5/15-mm stent (Dynamic, Biotronik, Buelach, Switzerland) was advanced over the wire and placed in the renal artery. Stenting was performed once on both sides in both animals (n ϭ 4). Stent position was verified in post mortem autopsy performed by veterinarian and FIGURE 2. Bending stiffness of the PEEK-based wire was examined in comparison with commercially available hydrophilic 0.035Љ guidewires (Stiff Shaft Glidewire and Standard Glidewire; Terumo, Leuwen, Belgium). Therefore, guidewires were fixated and along its axes, and forces were documented, that were needed to bend the wires by 3 mm using a caliper (A). The gap between the fixation of the guidewire and the mechanical caliper was 10 mm for all measurements. Measurements were performed for varying distances (ϫ) from the guidewires tip. Each point in the graph (B) corresponds to the average of 3 measurements. The distal, floppy, and thereby atraumatic portion of the PEEK-based guidewire is comparable with other commercially available hydrophilic guidewires in its bending stiffness. Proximal to this, the PEEK-based wire is softer than the Stiff Shaft Glidewire, but still comparable with the Standard Glidewire.
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PEEK-Based Guidewire: MR-Guided Angioplasty surgeon (S.A. and G.M.K.). Procedure times were recorded. Success rates (2 grades: Ϯ) of any procedure step were documented and guidewire visibility, pushability, steerability, and device support (3 grades: poor ͓ϩ͔; acceptable ͓ϩϩ͔; good ͓ϩϩϩ͔) were each assessed in consensus by the procedure performing interventional radiologists.
RESULTS
PEEK-Based Guidewire
For photographical, cross section, and a schematic illustration of the newly developed guide wire see Figure 1 . The newly developed 0.035" MR-compatible guidewire is 160 cm long. The wire has a PEEK core which is glass fiber reinforced, to increase its bending stiffness and allow straightening of the guidewire, when released from the storage screw. The core compound (0.57 mm diameter) is tapered at the 120-mm long flexible distal part to a minimal diameter of 0.15 mm at the 20-mm long floppy and thereby atraumatic, shapeable tip of the wire. The whole guidewire is rounded and coated by polyurethane polymer jacket and a hydrophilic coating, yielding a final diameter of 0.035" along the whole length of the guidewire.
Bending Stiffness
The results are shown in Figure 2 . Bending stiffness was comparable between the newly developed guidewire used in our experiments ( Fig. 1 ) and the commercially available hydrophilic guidewires (Terumo-stiff and Terumo standard) on the distal 90 to 100 mm of the wire. Further proximal along the shaft of the wire the bending stiffness was still comparable with the Terumo Glidewire Standard, but far (ϳ2.5 fold) softer then the Stiff Glidewire.
In the phantom and animal studies, we were able to visualize all passively marked endovascular devices by MR-imaging alone. The combination of marked nonbraided catheters and marked PEEK-based guidewire enabled us to precisely track the procedures.
Phantom Studies
For an illustration of PTRA in the phantom experiments see Figure 3 . Guidewire guidance, catheter configuration, renal artery catheterization as well as angioplasty were successful in all attempts. Mean procedure time was 5 minutes (standard deviation 2 minutes). The guidewire offered either good (ϩϩϩ) pushability, steerability, and device support. Visibility was rated acceptable (ϩϩ).
Animal Experiments
TrueFISP imaging, as used in the phantom studies suffered from susceptibility artifacts in vivo, did not allow precise device tracking and thus has been replaced by contrast-enhanced T1-FLASH imaging for the remainder of the animal experiments Intra-arterial 3D CE-MRA (3D-FLASH) using gadofosveset (0.03 mmol/kg) off-label documented correct intra-arterial catheter positioning in the renal arteries and showed no signs of complications (eg, renal infarction, arterial perforation, arterial dissection) (Fig. 7) .
Post mortem autopsy revealed correct stent positioning (Fig.  8) . The mean procedure times were 10 minutes (standard deviation 2 minutes) for PTRA and 12 minutes (standard deviation: 3 minutes) for stenting of the renal arteries. The guidewire offered either good (ϩϩϩ) pushability, steerability, and device support. Visibility was acceptable (ϩϩ). No procedure related complications occurred.
DISCUSSION
Our study demonstrates a newly developed hydrophilic PEEK-based guidewire allowing MR-guided endovascular interventions. Bending stiffness of the new guidewire was comparable with the hydrophilic Glidewire Standard, thereby allowing the usage of catheters, balloons and stents over the wire. Both phantom and animal studies proved that device visualization and tracking is well and safely feasible applying a passive marker system to the surface of the PEEK-based guidewire and nonbraided catheters.
The first prototype of a PEEK-based MR-compatible guidewire had a pure plastic PEEK core. 13 Simple plastic guidewires are safe, but too floppy and therefore do not support the usage of catheters, balloons, and stents over the wire. Furthermore the memory effect of plastic hampers straightening of the wire after its configuration or even storage in a screw. Because of this, a first study in humans, treating coarctation used a pure PEEK-based guidewire only as a backup for the PTA balloon to minimize dislocation during PTA. The prior placement of catheter, sheath and balloon was performed using a standard metallic guidewire. 27 A core compound solution is favorable as fiberglass alone is rigid, offering good pushability, but less resistant to torque, which may lead to core fracture. By adding PEEK to the core compound, being less rigid, the fracture risk is minimized and torquability increased. The core compound has to be tapered at its distal end, to gain a soft and thereby atraumatic tip, increasing procedure safety. An additional hydrophilic coating, consisting of polyure- thane is applied in many guidewires on the market (eg, Terumo Glidewire) to allow better movement through tortuous vessels and stenotic lesions.
The bending stiffness of the distal, floppy portion of the new PEEK-based guidewire is comparable with other commercially available hydrophilic guidewires. This is of crucial importance as this part of the wire includes the atraumatic tip, which is used for sounding and guidance. Of course bending stiffness alone can give a first impression on the stiffness of the wire, but is unable to fully characterize the mechanical properties of the guidewire. Further performance parameters (eg, torquability, tip flexibility, coating adherence, coating integrity, biocompatibility, and catheter compatibility) will have to be assessed before its usage in human. In earlier studies, endovascular procedures were performed and stents deployed, using either potentially harmful standard metallic or metallic-core guidewires, or even without using any guidewire. The first bearing the risk of device heating or spark yielding, the latter increasing the risk of vessel dissection, or perforation. 9 -11,28,29 Both techniques have to be considered unsafe in vivo and must not be performed. By its mechanical properties, the new guidewire provided both excellent pushability and device support and thereby high success rates of the procedures performed in this study.
PEEK-based guidewire and nonbraided catheters were successfully usable with standard interventional techniques for PTRA (100%) and renal artery stenting (100%). This is equal to the technical success rate (100%) in another study, stenting stenosed renal arteries in 6 swine. 9 Most likely because of the absence of stenoses in our animal study, the success rate is superior to a study treating RAS with PTRA in 11 swine (82%). 8 Mean procedure times in our study (10 minutes for PTRA and 12 minutes for stenting) were much lower than those reported in the latter study (mean: 77 minutes), treating 11 swine with PTRA. 8 This again may partially be explained by the absence of RAS in our animal study. However, technical simplicity in our study using passively marked devices instead of technically more sophisticated actively tracked devices (eg, loopless antenna guidewire coil in the other study) may well be a time saving factor. Furthermore, the application of single-shot intravenous road-map imaging using gadofosveset clearly accelerates the procedure, as it makes intermittent acquisition of 3D CE-MRA unnecessary. The usage of standard interventional techniques in our study may be another timesaving factor and may facilitate the clinical transfer of endovascular interventions from the angio-suite into the interventional MR unit in the future.
The passive-marking concept applied in this study provides acceptable visibility of either guidewire (ϩϩ) and nonbraided catheters. This is mandatory for safety and success of any endovascular intervention. This passive-marking technique allows precise modification of the marker size.
Using the passive technique, the markers size must be chosen to offer sufficient visibility even in vivo with physiological factors like heart beat, breathing, and bowel movement hampering visualization. The space between distinct markers has to be chosen, so that the created artifacts do not overlap, but on the other hand still allow depiction of the device configuration in its functional distal part and along its axis.
In our study, we used relatively broad markings (1.5 mm) on the devices to securely allow device detection and tracking in vivo. However, the created artifact may obscure the whole vessel lumen and anatomy in smaller vessels. These smaller and distal vessels (eg, lower leg and foot) can be precisely already depicted by MRA and may therefore become a target for MR-guided interventions in the future. 30 Addressing this, additional studies, titrating the best relation between marker size, artifact size, and in vivo visibility will be needed. Additionally, it is known that in the passive visualization approaches the displayed marker size is a function of the magnetic field strength, the sequence type, and imaging protocol used and may also depend on device orientation. 31 Therefore, sequence optimization may further facilitate marker and therefore device detection.
Stents and balloons used in this study were unmodified, commercially available products. These were visualized in our study based on the small susceptibility artifact related to the attached x-ray markers. This may in the future be optimized by applying the above described passive-marking technique on these products either. As in this scenario, passive markings of guidewire, stent, and balloon may overlap and thereby obscure each other, a combination of a passive and an active tracking approach might be beneficial. 32 The stents which were deployed in this study in vivo produced a relatively big susceptibility artifact, thereby obscuring the vessel lumen. As they were chosen based on availability, this may be optimized by using stents with better MR-visibility (eg, Omnilink, Wallstent, Luminexx, Jostent). 33 Furthermore, even metallic MR artifact-free stent was described and may be usable. 34 Usage of such stents, in combination with modified passive markings, offering the best relation between marker size, artifact size, and in vivo visibility, should in the future allow targeted PTA and stenting of small arteries even in specific stenotic segments (eg, ostial lesions). To demonstrate this was not intended in this first feasibility study, using guidewire and stents creating comparably broad artifacts, thereby being well visible, but of course reducing the precision of its positioning and deployment. The setup as used in this study would not yet allow precise treatment of eg, an ostial renal artery stenosis, requiring stent placement 2 mm into the abdominal aorta.
The in vitro experiments in this study have been performed using a fast TrueFISP sequence. TrueFISP is an often favored imaging sequence when steering MR-guided vascular interventions. 20, 35 Although the TrueFISP sequence was performed also well in the in vitro experiments of this study, image quality in the in vivo experiments was somewhat degraded. It was observed that downstream of marked guidewire the blood signal was disturbed, leading to blood-signal reduction thus hampering instrument visualization. The imaging strategy was thus to switch to fast FLASH imaging for the in vivo experiments. The fact that native FLASH imaging suffers from inherently reduced contrast when compared with TrueFISP was successfully compensated because of the use of gadofosveset that increased the blood signal and thus vessel contrast and made device detection more robust and precise.
A recent study described the usability of a noncontrast 3D steady-state free-precession MRA using nonselective RF excitation for depiction of the whole chest. 36 This technique allows precise vessel depiction without contrast usage, but scan times of 5 to 10 minutes make its usability for procedure control for MR-guided endovascular interventions unlikely. However, it may assist preinterventional intervention planning and may even be used for postinterventional controls.
This study used phantom experiments and animal studies for the evaluation of the PEEK-based guidewire. As young pigs not suffering from atherosclerosis were used and as we did not artificially induce RAS in vivo, this model does not allow a conclusion on the effectiveness of such a treatment. However, as other studies already demonstrated that this is MR-guided feasible with results equal to PTRA under angiographic guidance, our focus and intention was to show the safety, visibility, steerability, and precise usability of the guidewire and its combination with catheters, balloons, and stents.
As the used guidewire is not yet certified, we did not treat humans. We tried to match this by choosing domestic pigs as the animal model, having a vascular anatomy, body weight, and vessel size similar to human. Furthermore, the silicon phantom was a replica derived from a human aorta. Of course additional human studies should be performed immediately after wire certification by the relevant authorities. JOBNAME: AUTHOR QUERIES PAGE: 1 SESS: 1 OUTPUT: Sat Feb 7 05:59:15 2009 /balt6/z7lϪir/z7lϪir/z7l00409/z7l2959Ϫ09z AQ1-Please confirm whether the word "theses" is OK as given.
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